Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Pitolisant hydrochloride by Harmony Biosciences for Myotonic Dystrophy: Likelihood of Approval
Pitolisant hydrochloride is under clinical development by Harmony Biosciences and currently in Phase II for Myotonic Dystrophy. According to GlobalData,...
Pitolisant hydrochloride by Harmony Biosciences for Cognitive Impairment: Likelihood of Approval
Pitolisant hydrochloride is under clinical development by Harmony Biosciences and currently in Phase II for Cognitive Impairment. According to GlobalData,...
Pitolisant hydrochloride by Harmony Biosciences for Fatigue: Likelihood of Approval
Pitolisant hydrochloride is under clinical development by Harmony Biosciences and currently in Phase II for Fatigue. According to GlobalData, Phase...
Pitolisant hydrochloride by Harmony Biosciences for Prader-Willi Syndrome (PWS): Likelihood of Approval
Pitolisant hydrochloride is under clinical development by Harmony Biosciences and currently in Phase III for Prader-Willi Syndrome (PWS). According to...